Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychedelics.

David E Nichols1

  • 1Eschelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina drdave@purdue.edu.

Pharmacological Reviews
|February 5, 2016
PubMed
Summary
This summary is machine-generated.

Psychedelics, acting on serotonin receptors, show promise in treating anxiety, depression, and addiction. Recent studies highlight their potential therapeutic benefits in clinical settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.

Neuron·2025
Same author

History of psychedelic drug science and molecular pharmacology.

International review of neurobiology·2025
Same author

5-HT<sub>2A</sub> receptors: Pharmacology and functional selectivity.

Pharmacological reviews·2025
Same author

Characterization of Gα<sub>s</sub> and Gα<sub>olf</sub> activation by catechol and non-catechol dopamine D1 receptor agonists.

iScience·2025
Same author

The structural diversity of psychedelic drug actions revealed.

Nature communications·2025
Same author

If Everything Is Psychedelic, Then Nothing Is: A Response to O'Donnell et al. and Lepow et al.

Psychedelic medicine (New Rochelle, N.Y.)·2025
Same journal

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

Pharmacological reviews·2026
Same journal

Mast cell proteases and their significance in physiology, pathology, and therapeutic approaches.

Pharmacological reviews·2026
Same journal

Translational medications development for methamphetamine use disorder: A systematic review of preclinical, human laboratory, and clinical research.

Pharmacological reviews·2026
Same journal

Reharnessing the therapeutic potential of gallium-based compounds in oncology: From the laboratory to the clinic.

Pharmacological reviews·2026
Same journal

Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions.

Pharmacological reviews·2026
Same journal

International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.

Pharmacological reviews·2026
See all related articles

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Clinical Psychology

Background:

  • Psychedelics are psychoactive substances with historical use in rituals.
  • Early research linked psychedelics to serotonin due to structural similarities.
  • Current understanding points to serotonin 5-HT2A receptor agonism as the primary mechanism.

Purpose of the Study:

  • To review the neurochemical basis of psychedelic action.
  • To explore recent clinical findings on psychedelic-assisted therapies.
  • To investigate the effects of psychedelics on brain activity.

Main Methods:

  • Review of existing literature on psychedelic pharmacology.
  • Analysis of clinical trial data for psilocybin-assisted psychotherapy.
  • In vivo brain imaging using fMRI and MEG.

Related Experiment Videos

Main Results:

  • Psychedelics are agonists/partial agonists at serotonin 5-HT2A receptors.
  • Psilocybin-assisted therapy shows significant relief for cancer-related anxiety and depression.
  • Pilot studies indicate efficacy in treating alcohol and nicotine addiction.
  • Brain imaging reveals decreased default mode network activity post-psilocybin and LSD administration.

Conclusions:

  • Psychedelics, particularly psilocybin, demonstrate therapeutic potential for various mental health conditions.
  • The serotonergic system, specifically 5-HT2A receptors, is crucial for psychedelic effects.
  • Further research and clinical trials are warranted to establish psychedelic-assisted therapies.